| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $132.0M | -3.8% |
| Cost of Revenue | $29.1M | -12.0% |
| Gross Profit | $102.9M | -1.2% |
| R&D Expense | $800K | -20.0% |
| SG&A Expense | $48.6M | +77.0% |
| Operating Income | -$964K | -138.0% |
| Pre-tax Income | -$1.1M | -135.9% |
| Income Tax | $1.1M | -72.4% |
| Net Income | -$2.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.7M | -43.9% |
| Accounts Receivable | $91K | -58.3% |
| Inventory | $14.5M | -1.3% |
| Current Assets | $27.7M | -20.9% |
| Total Assets | $41.2M | -16.1% |
| Current Liabilities | $25.8M | -13.6% |
| Total Liabilities | $30.7M | -12.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | +8.8% |
| Capital Expenditures | $748K | -29.6% |
| Investing Cash Flow | -$747K | +29.7% |
| Financing Cash Flow | -$1.9M | +56.1% |
| Free Cash Flow | -$3.1M | +14.9% |
| +50.1% |
| EPS (Basic) | -$1.20 | +48.9% |
| EPS (Diluted) | -$1.20 | +48.9% |
| Stockholders' Equity |
| $10.5M |
| -26.0% |